Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Efficacy, safety, and patient-reported outcome of immune checkpoint inhibitor in gynecologic cancers: A systematic review and meta-analysis of randomized controlled trials

  • Fitriyadi Kusuma,
  • Glenardi Glenardi,
  • Ghea Mangkuliguna,
  • Hariyono Winarto,
  • Gatot Purwoto,
  • Tofan Widya Utami,
  • Tricia Dewi Anggraeni

There is an error in affiliation 1 for authors Fitriyadi Kusuma, Glenardi Glenardi, Hariyono Winarto, Gatot Purwoto, Tofan Widya Utami and Tricia Dewi Anggraeni. The correct affiliation 1 is: Faculty of Medicine Universitas Indonesia, Department of Obstetrics and Gynecology, Division of Oncology Gynecology, Dr. Cipto Mangunkusumo Hospital, Greater Jakarta, DKI Jakarta, Indonesia.

Reference

  1. 1. Kusuma F, Glenardi G, Mangkuliguna G, Winarto H, Purwoto G, Utami TW, et al. (2024) Efficacy, safety, and patient-reported outcome of immune checkpoint inhibitor in gynecologic cancers: A systematic review and meta-analysis of randomized controlled trials. PLOS ONE 19(8): e0307800. pmid:39133693

Citation: Kusuma F, Glenardi G, Mangkuliguna G, Winarto H, Purwoto G, Utami TW, et al. (2024) Correction: Efficacy, safety, and patient-reported outcome of immune checkpoint inhibitor in gynecologic cancers: A systematic review and meta-analysis of randomized controlled trials. PLoS ONE 19(12): e0316871. https://doi.org/10.1371/journal.pone.0316871

Published: December 30, 2024

Copyright: © 2024 Kusuma et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.